Efficacy of securing urinary catheter in the reduction of urinary tract infections in the critical patients

ISRCTN ISRCTN11342326
DOI https://doi.org/10.1186/ISRCTN11342326
Secondary identifying numbers BSI2018-19.01
Submission date
02/11/2023
Registration date
06/11/2023
Last edited
06/11/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Clinical guidelines for preventing urinary tract infections related to catheters suggest securing urinary catheters for critically ill patients, even though there is limited research on how well this works. This study's goal is to investigate if properly securing a urinary catheter can lower the chances of getting a urinary tract infection from the catheter and prevent any injuries around the urinary meatus in patients in the intensive care unit.

Who can participate?
Patients aged 18 years and above who are admitted to the Intensive Care Unit (ICU) and are expected to need a urinary catheter for more than 48 hours during their stay in the ICU. The catheter should be put in either in the ICU or the operating room, and the patient must have given their informed consent by signing a document.

What does the study involve?
In the intervention group, the urinary catheter is secured to the thigh using an in-house device, it means that H-shaped pieces of tape must be cuted. A team of 6 nurses are needed so as to control involved patients.

What are the possible benefits and risks of participating?
Patients in the intervention group may experience some discomfort related to the adhesive.

Where is the study run from?
Universitat Internacional de Catalunya (Spain)

When is the study starting and how long is it expected to run for?
July 2017 to June 2021

Who is funding the study?
This study was granted by the Sociedad Española de Enfermería Intensiva y Unidades Coronarias (Spain)

Who is the contact?
Neus Calpe Damians, neuscalpe@uic.es

Contact information

Dr Neus Calpe Damians
Public, Scientific, Principal Investigator

C/ de Josep Trueta
Sant Cugat del Vallès
Barcelona
08195
Spain

ORCiD logoORCID ID 0000-0003-2709-9322
Phone +34 935 04 20 00
Email neuscalpe@uic.es

Study information

Study designMulticenter interventional non blinded randomized clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention, Safety, Efficacy
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet.
Scientific titleEffectiveness and safety profile of a simple catheter securement device aimed at preventing catheter-associated urinary tract infection in intensive care unit patients
Study objectivesSecuring urinary catheter to the thigh decreases the incidence of catheter-associated urinary tact infection, as well as injuries to the meatus.
Ethics approval(s)

1. Approved 06/02/2018, Ethical Committee of the Universitat Internacional de Catalunya (C/ de Josep Trueta, Sant Cugat del Vallès, 08195, Spain; +34 935 04 20 00; nnogales@uic.es), ref: INF-218-01

2. Approved 04/07/2017, Ethical Committee of the Hospital Universitari General de Catalunya. (C/Pere i Pons, 1, Sant Cugat del Vallès, 08195, Spain; +34 935656000; mgranados@quironsalud.es), ref: 2017/03-INF-HUGC

Health condition(s) or problem(s) studiedCatheter Associated Urinary Tract Infetion (CAUTI)
Meatal Pressure Injuries
Intervention Patients in the Control Group received care as usual, which included non-securement of the urinary catheter. In the Intervention Group, the urinary catheter was secured to the thigh using a simple in-house adhesive device made with a piece of adhesive tape cut in the form of an H, adapted for female and male patients, enabling the catheter to be secured without it resting directly against the skin, that was piloted as part of the present study. Alcohol-free barrier film spray was applied to prevent Medical Adhesive Related Skin Injuries, as described above. The exact site of securement was determined with the patient's leg bent, leaving sufficient slack to avoid traction with posterior movements. The date of securement was written manually on the device, which was replaced every 72 hours, or sooner if necessary.

The patient’s participation in the trial ended when one or more of the following circumstances happened: after 30 days of catheterisation, if a CAUTI was diagnosed, 48 hours after catheter removal, 48 hours after ICU discharge or in the event of death.

Patients were included using non-probability consecutive sampling and were randomised 1:1 to either the Intervention Group or Control Group using the RANDOMIZER® online tool.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Urinary catheter securement device
Primary outcome measureCatheter-associated Urinary Tract Infection measured every 12 hours. A urinary Tract Infection was diagnosed according to the criteria of the European Centre for Disease Prevention and Control, namely at least one of the following symptoms with no other recognised cause: fever (> 38 °C), urgency, frequency, dysuria or suprapubic tenderness – and a positive urine culture, i.e. ≥ 105 microorganisms per ml of urine with no more than two species of microorganisms. Data from this variable were collected reviewing patient notes.
Secondary outcome measuresMeatal pressure injury categorized according to the 1–4 grade classification system of the EPUAP–European Pressure Ulcer Advisory Panel. Data from this variable were collected by direct observation every 12 hours.
Overall study start date01/07/2017
Completion date01/06/2021

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit100 Years
SexBoth
Target number of participants598
Total final enrolment350
Key inclusion criteria1. Age >18 years
2. Expected duration of the urinary catheter and length of stay in the intensive care unit >48 hours
3. Urinary catheter inserted in the intensive care unit or in the operating room
4. Signed informed consent
Key exclusion criteria1. Securing not possible
2. Urinary infection or suspicion on admission
3. Allergy to adhesive tape
4. Urinary or prostatic pathology
Date of first enrolment01/09/2017
Date of final enrolment20/02/2020

Locations

Countries of recruitment

  • Spain

Study participating centres

Hospital Universitari General de Catalunya
C/Pere i Pons, 1
Sant Cugat del Vallès
08195
Spain
Hospital Parc Salut Mar
Passeig Marítim de la Barceloneta, 25, 29
Barcelona
08003
Spain

Sponsor information

Universitat Internacional de Catalunya
University/education

C/ de Josep Trueta
Sant Cugat del Vallès
Barcelona
08195
Spain

Phone +34 935 04 20 00
Email mllaurado@uic.es
Website https://www.uic.es
ROR logo "ROR" https://ror.org/00tse2b39

Funders

Funder type

Research organisation

Sociedad Española de Enfermería Intensiva y Unidades Coronarias (Spanish Society of Intensive Care and Coronary Care Nurses)

No information available

Results and Publications

Intention to publish date01/01/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated and/or analysed during the study will be avaliable upon request from Neus Calpe (neuscalpe@uic.es)

Editorial Notes

06/11/2023: Trial's existence confirmed by Ethical Committee of the Universitat Internacional de Catalunya.